Hisashi Doi

Hisashi Doi

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMAsuka Morizane
Asuka Morizane
TKTetsuhiro Kikuchi
Tetsuhiro Kikuchi
THTakuya Hayashi
Takuya Hayashi
HMHiroshi Mizuma
Hiroshi Mizuma
STSayuki Takara
Sayuki Takara
JTJun Takahashi
Jun Takahashi
The banking of human leukocyte antigen (HLA)-homozygous-induced pluripotent stem cells (iPSCs) is considered a future clinical strategy for HLA-matched cell transplantation to reduce immunological graft rejection. Here we show the efficacy of major histocompatibility complex (MHC)-matched allogeneic neural cell grafting in the brain, which is considered a less immune-responsive tissue, using iPSCs derived from an MHC homozygous cynomolgus macaque. Positron emission tomography imaging reveals neuroinflammation associated with an immune response against MHC-mismatched grafted cells. Immunohistological analyses reveal that MHC-matching reduces the immune response by suppressing the accumulation of microglia (Iba-1+) and lymphocytes (CD45+) into the grafts. Consequently, MHC-matching increases the survival of grafted dopamine neurons (tyrosine hydroxylase: TH+). The effect of an immunosuppressant, Tacrolimus, is also confirmed in the same experimental setting. Our results demonstrate the rationale for MHC-matching in neural cell grafting to the brain and its feasibility in a clinical setting.

12 April 2012 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
TTTadayuki Takashima
Tadayuki Takashima
SKSatoshi Kitamura
Satoshi Kitamura
YWYasuhiro Wada
Yasuhiro Wada
MTMasaaki Tanaka
Masaaki Tanaka
YSYoshihito Shigihara
Yoshihito Shigihara
YWYasuyoshi Watanabe
Yasuyoshi Watanabe
It is well accepted that drug transporters play a pivotal role in hepatobiliary excretion of anionic drugs, in which drug–drug interactions and genetic polymorphisms are known to cause variations. However, PET probes for in vivo functional characterization of these transporters have not been established yet. We used PET to investigate hepatic uptake and subsequent canalicular efflux of 11C-labeled (15R)-16-m-tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester [(15R)-11C-TIC-Me)] in healthy subjects. Methods: Serial PET scans of the abdominal region in healthy male subjects were obtained with or without the organic anion–transporting polypeptide (OATP) inhibitor rifampicin after intravenous injection of (15R)-11C-TIC-Me as a radiotracer. Venous blood samples and PET images were obtained at frequent intervals up to 30 min after administration of the PET tracer. Dynamic imaging data were evaluated by integration plots of data collected for 2–10 min and for 10–30 min after tracer administration for the determination of tissue uptake clearance and biliary efflux clearance, respectively. Results: After rapid hydrolysis in blood, the acid form—11C-labeled (15R)-16-m-tolyl-17,18,19,20-tetranorisocarbacyclin [(15R)-11C-TIC]—accumulated in the liver (37% of the dose by 17 min), and the radioactivity was then excreted into the bile (6.2% by 30 min). Rifampicin (600 mg by mouth), a potent OATP inhibitor, significantly reduced the radioactivity excreted into the bile (by 44%) by inhibiting both uptake (by 45%) and subsequent canalicular efflux (by 62%). (15R)-11C-TIC is an in vitro substrate of OATP1B1 and OATP1B3, and clinically relevant concentrations of rifampicin inhibited uptake by OATP1B1 and OATP1B3. These results demonstrated that in humans, (15R)-11C-TIC–associated radioactivity is excreted into the bile by organic anion transport systems. Conclusion: We demonstrated that PET image analysis with (15R)-11C-TIC-Me is useful for investigating variations in OATP function in the human hepatobiliary transport system.


7 January 2014 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
HYH Yamanaka
H Yamanaka
CYC Yokoyama
C Yokoyama
HMH Mizuma
H Mizuma
SKS Kurai
S Kurai
SFS J Finnema
S J Finnema
HOH Onoe
H Onoe
Ketamine is a unique anesthetic reagent known to produce various psychotic symptoms. Ketamine has recently been reported to elicit a long-lasting antidepressant effect in patients with major depression. Although recent studies provide insight into the molecular mechanisms of the effects of ketamine, the antidepressant mechanism has not been fully elucidated. To understand the involvement of the brain serotonergic system in the actions of ketamine, we performed a positron emission tomography (PET) study on non-human primates. Four rhesus monkeys underwent PET studies with two serotonin (5-HT)-related PET radioligands, [11C]AZ10419369 and [11C]DASB, which are highly selective for the 5-HT1B receptor and serotonin transporter (SERT), respectively. Voxel-based analysis using standardized brain images revealed that ketamine administration significantly increased 5-HT1B receptor binding in the nucleus accumbens and ventral pallidum, whereas it significantly reduced SERT binding in these brain regions. Fenfluramine, a 5-HT releaser, significantly decreased 5-HT1B receptor binding, but no additional effect was observed when it was administered with ketamine. Furthermore, pretreatment with 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX), a potent antagonist of the glutamate α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor, blocked the action of ketamine on the 5-HT1B receptor but not SERT binding. This indicates the involvement of AMPA receptor activation in ketamine-induced alterations of 5-HT1B receptor binding. Because NBQX is known to block the antidepressant effect of ketamine in rodents, alterations in the serotonergic neurotransmission, particularly upregulation of postsynaptic 5-HT1B receptors in the nucleus accumbens and ventral pallidum may be critically involved in the antidepressant action of ketamine.

16 June 2011 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
MSMiho Shukuri
Miho Shukuri
MTMisato Takashima-Hirano
Misato Takashima-Hirano
KTKeiko Tokuda
Keiko Tokuda
TTTadayuki Takashima
Tadayuki Takashima
KMKiyoshi Matsumura
Kiyoshi Matsumura
HOHirotaka Onoe
Hirotaka Onoe
Cyclooxygenase (COX)-1 and -2 are prostanoid-synthesizing enzymes that play important roles in the regulation of neuroinflammation and in the development of neurodegenerative disorders. However, the specific functions of these isoforms are still unclear. We recently developed 11C-labeled ketoprofen methyl ester as a PET probe that targets the COXs for imaging neuroinflammation, though its responsible isoform is yet to be determined. In the present study, we performed ex vivo and in vivo imaging studies with 11C-ketoprofen methyl ester and determined the contributions of the COX isoforms during the neuroinflammatory process. Methods: To identify the COX isoform responsible for 11C-ketoprofen methyl ester in the brain, we examined the ex vivo autoradiography of 11C-ketoprofen methyl ester using COX-deficient mice. Time-dependent changes in accumulation of 11C-ketoprofen methyl ester during the neuroinflammatory process were evaluated by PET in rats with hemispheric neuroinflammation induced by intrastriatal injection of lipopolysaccharide or quinolinic acid. In both rat models, cell-type specificity of COX isoform expression during neuroinflammation was identified immunohistochemically. Results: Ex vivo autoradiographic analysis of COX-deficient mice revealed a significant reduction of 11C-ketoprofen methyl ester accumulation only in COX-1–deficient mice, not COX-2–deficient mice. PET of rats after intrastriatal injection of lipopolysaccharide showed a significant increase in accumulation of 11C-ketoprofen methyl ester in the inflamed area. This increase was evident at the early phase of 6 h, peaked at day 1, and then returned to basal levels by day 7. In addition, immunohistochemical analysis revealed that the population of activated microglia and macrophages was elevated at the early phase with COX-1 expression but not COX-2. A significant increase in 11C-ketoprofen methyl ester accumulation was also observed at day 1 after intrastriatal injection of quinolinic acid, with increased COX-1–expressing activated microglia and macrophages. Conclusion: We have identified 11C-ketoprofen methyl ester as a COX-1–selective PET probe, and using this, we have also demonstrated a time-dependent expression of COX-1 in activated microglia and macrophages during the neuroinflammatory process in the living brain. Thus, COX-1 may play a crucial role in the pathology of neuroinflammation and might be a critical target for the diagnosis and therapy of neurodegenerative disorders.

1 December 1997 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
MSMasaaki Suzuki
Masaaki Suzuki
HDHisashi Doi
Hisashi Doi
MBMargareta Björkman
Margareta Björkman
YAYvonne Andersson
Yvonne Andersson
BLBengt Långström
Bengt Långström
RNRyoji Noyori
Ryoji Noyori